Kir2.1(KCNJ2) is associated with the development of papillary thyroid carcinoma(PTC), and interference with KCNJ2 inhibits cell proliferation, invasion, migration, and EMT processes (38). This evidence concerns the gene KCNJ2 and thyroid gland papillary carcinoma.